Showing results (111-120 of 168) with videos related to
Sort By:
Pageof 17
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|November 30, 2016
Safety of regadenoson stress testing in patients with pulmonary hypertensionVictor M Moles, Thomas Cascino, Ashraf Saleh, et al.Advances in Therapy|November 2, 2021
Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label ExtensionNazzareno Galiè, Sean Gaine, Richard Channick, et al.Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|February 21, 2015
[Updated treatment algorithm of pulmonary arterial hypertension]Nazzareno Galiè, Paul A Corris, Adaani Frost, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 8, 2018
Initial combination therapy with ambrisentan + tadalafil on pulmonary arterial hypertension‒related hospitalization in the AMBITION trialJean-Luc Vachiéry, Nazzareno Galiè, Joan Albert Barberá, et al.Arthritis and Rheumatism|September 12, 2013
Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertensionDinesh Khanna, Heather Gladue, Richard Channick, et al.Respiratory Research|September 13, 2019
Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertensionR James White, Anton Vonk-Noordegraaf, Stephan Rosenkranz, et al.European Journal of Heart Failure|November 22, 2021
The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON studyStephan Rosenkranz, Richard Channick, Kelly M Chin, et al.Journal of the American College of Cardiology|December 21, 2013
Updated treatment algorithm of pulmonary arterial hypertensionNazzareno Galiè, Paul A Corris, Adaani Frost, et al.Circulation|April 16, 2019
Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial HypertensionKelly M Chin, Lewis J Rubin, Richard Channick, et al.Journal of the American College of Cardiology|October 1, 2021
Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial HypertensionKelly M Chin, Olivier Sitbon, Martin Doelberg, et al.Pageof 17